Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 6/20 | 0.39 |
| ▸ | CES2 | O00748 | 6/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10599714 | 0.98 | CA1 (0.41) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL332305 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL10495891 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL6277014 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL17472936 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| Silver SCHEMBL25380476 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL8939650 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL17476400 | 0.95 | CA1 (0.44) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL652779 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL332306 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220227969-A1 | ROOM TEMPERATURE CURABLE COMPOSITION | INVENTO IND (IN) | 2022-07-21 | — | — | US | claimed |
| CN-114713223-A | Method for preparing tetragonal-phase zirconia in one step, copper-based supported catalyst and application thereof | 中国科学院大连化学物理研究所 | 2022-07-08 | — | — | CN | claimed |
| CN-113978061-A | Preparation method of copper-clad plate with low dielectric constant, low dielectric loss and low CTE | 山东金宝电子股份有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-113844129-A | Preparation method of halogen-free copper-clad plate with low dielectric loss and high heat resistance | 山东金宝电子股份有限公司 | 2021-12-28 | — | — | CN | claimed |
| CN-113795552-A | Room temperature curable composition | 因温特实业公司 | 2021-12-14 | — | — | CN | claimed |
| WO-2020230152-A1 | A ROOM TEMPERATURE CURABLE COMPOSITION | INVENTO INDUSTRIES (IN) | 2020-11-19 | — | — | WO | claimed |
| US-7553901-B2 | RTV silicone rubber composition for electric and electronic part protection, circuit boards, silver electrodes, and silver chip resistors | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-06-30 | — | — | US | claimed |
| WO-2009070284-A1 | A DELINKED POLYMER MODIFIED BITUMEN AND METHOD OF PRODUCING SAME | SEMMATERIALS, L.P. (US) | 2009-06-04 | — | — | WO | claimed |
| US-20090137690-A1 | Delinked Polymer Modified Bitumen and Method of Producing Same | SEMMATERIALS, L.P. (US) | 2009-05-28 | — | — | US | claimed |
| US-11993727-B2 | Antifouling coating film and method of manufacturing same, water contacting structure with antifouling coating film, and antifouling tape and method of manufacturing same | CHUGOKU MARINE PAINTS, LTD. (JP) | 2024-05-28 | — | — | US | disclosed |
| EP-3594220-B1 | ORGANOSILICON COMPOUND AND METHOD FOR PRODUCING SAME | SHINETSU CHEMICAL CO (JP) | 2024-05-08 | — | — | EP | disclosed |
| EP-3467044-B1 | THERMALLY CONDUCTIVE SILICONE COMPOSITION AND CURED PRODUCT THEREOF | SHINETSU CHEMICAL CO (JP) | 2024-04-24 | — | — | EP | disclosed |
| EP-4353755-A1 | CURABLE COMPOSITION AND CURED PRODUCT | Soken Chemical & Engineering Co., Ltd. (JP) | 2024-04-17 | — | — | EP | disclosed |
| US-20240092976-A1 | CONDENSATION-CURABLE SILICONE COMPOSITION, A CURED PRODUCT, AND A METHOD FOR PREPARING THE CURED PRODUCT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-03-21 | — | — | US | disclosed |
| US-5733995-A | BLEND CONTAINING IMINOOXYSILANE, AMINO GROUP CONTAINING SILANE AND CURING AGENTS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1998-03-31 | — | — | US | disclosed |
| US-5574123-A | CURES WITHOUT BLISTERS EVEN AFTER STORAGE | BAYER AKTIENGESELLSCHAFT (DE) | 1996-11-12 | — | — | US | disclosed |
| EP-0508259-B1 | Reactive adhesive in one compound based upon polyurethane | BAYER AG (DE) | 1996-06-05 | — | — | EP | disclosed |
| US-5510141-A | Coating composition and method for forming thin film on substrate using same | CENTRAL GLASS COMPANY, LIMITED (JP) | 1996-04-23 | — | — | US | disclosed |
| EP-0671423-A1 | Process for the preparation of thermosetting one-component-polyurethane reactive masses | BAYER AG (DE) | 1995-09-13 | — | — | EP | disclosed |
| EP-0508259-A1 | Reactive adhesive in one compound based upon polyurethane | BAYER AG (DE) | 1992-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11993727-B2 | Antifouling coating film and method of manufacturing same, water contacting structure with antifouling coating film, and antifouling tape and method of manufacturing same | ZFP3, RCSD1, NOTUM | CA1 735/4885CES1 1777/4885CES2 1281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.